Regulatory Document Accuracy KPI

What is Regulatory Document Accuracy?
The accuracy of documents submitted to regulatory agencies, indicating the attention to detail and correctness in the reporting.

View Benchmarks




Regulatory Document Accuracy is crucial for maintaining compliance and minimizing legal risks.

High accuracy rates directly influence operational efficiency and financial health, enabling organizations to avoid costly penalties.

This KPI serves as a leading indicator for overall business performance, as inaccuracies can lead to significant delays in project timelines and resource allocation.

By tracking results in this area, companies can ensure they meet industry standards and improve their strategic alignment.

Effective management reporting on this metric helps drive data-driven decision-making, ultimately enhancing ROI and forecasting accuracy.

How Regulatory Document Accuracy Connects to Your Strategy

Regulatory Document Accuracy sits in one KPI group in KPI Depot's graph: Regulatory Affairs. That KPI group tracks fifty eight metrics in total, and within it this KPI is a supporting metric rather than one of the group's headline indicators. The KPI group's top ranked members, in priority order, are Regulatory Compliance Rate, Safety Incident Reporting Compliance, Data Privacy Compliance Rate, Anti-Corruption Compliance Rate, Environmental Compliance Rate, Pharmacovigilance Compliance Rate, Anti-Money Laundering (AML) Compliance Rate, and Chemical Substance Compliance Rate. Document accuracy backs those broader compliance rates instead of competing with them for a spot at the top of the scorecard.

The KPI group places this metric in the internal perspective of the balanced scorecard, and that placement says something about how to read it. It is not an outcome a board sees directly. It is a process control on what a team produces before that output ever reaches a regulator or an internal audit. Read that way, it functions as a leading indicator for the group's more outcome facing metrics. Regulatory Affairs also tracks Regulatory Audit Pass Rate and Regulatory Issue Resolution Time, both of which register the downstream consequences of the same drafting and review work this metric watches earlier in the process. A run of accurate documents this quarter is the leading signal behind a clean audit or a short issue resolution cycle later, not the reverse.

The clearest tension inside this KPI group runs between document accuracy and Regulatory Filings Timeliness, a metric the group's own guidance flags as one of the first to implement because of how directly it drives filing outcomes. Pressure to hit a filing date shortens the time available for review and correction, and a team that protects its timeliness numbers by compressing quality control will see accuracy slip first, quietly, before it shows up in an audit finding or a deficiency letter. The trade runs both ways. A review cycle rebuilt to catch every error will miss dates just as easily. Regulatory Affairs works only when someone owns that trade on purpose rather than letting one metric win by default.

Measuring Regulatory Document Accuracy in Practice

The raw material for this KPI usually lives in two systems that do not talk to each other by default: a regulatory submission or document management platform that tracks drafts, versions, and sign offs, and a technical validation log, often generated automatically by submission software, that records which checks a document passed or failed before it went out the door. Joining those honestly means deciding, before counting anything, whether an internal QC sign off, a passed technical validation, and an agency's own acceptance are being treated as the same event or three different ones. They are not the same, and the FDA's own reporting on this exact metric shows why: a document can clear an internal check and still fail a downstream validation, or clear validation and still draw a substantive comment from a reviewer months later.

Three forks need resolving before a customer measures this KPI at all, and each one mechanically changes the reported rate on its own. First, what counts as a document: a single file, a full submission module, or an entire regulatory dossier. Counting at the dossier level can make one filing with a single flaw look like one error against a denominator of one, while counting every file inside that same dossier spreads the same flaw thin across many. Second, at what point a document gets scored: at internal sign off, at the moment of submission, or only once the regulator responds. Scoring early catches process discipline; scoring late catches what the regulator actually thought, and the two will diverge. Third, what qualifies as an error at all: a technical or formatting defect caught by automated validation, or a substantive content problem a reviewer raises well after filing. A metric built only on the first kind will look strong while genuine content quality problems accumulate unseen in the second.

Segment this KPI by document or submission type before trusting a single blended number. An original application and a routine supplement or amendment carry very different review complexity and are usually drafted by different teams under different time pressure, so a blended accuracy figure can hide a real problem in one category behind strong performance in another. If filings span more than one country or agency, segment by jurisdiction too, since format and content requirements differ enough that a document built to satisfy one regulator can trip an unrelated check for another. It is also worth marking the date of any template, tool, or standard operating procedure change and segmenting before and after it. A fix that actually works should produce a visible step change in the data, and pooling the two periods together hides whether it worked at all.

Watch for three specific ways this metric gets distorted without anyone intending it. An error free count that credits only automated technical validation will miss substantive review comments entirely and will read healthier than the real submission quality. Treating a corrected resubmission as a brand new document, rather than as a fix to the original, lets a mistake quietly disappear from the count instead of counting against the team that made it. Excluding withdrawn submissions from the denominator flatters the rate, because the weakest documents leave the count before they are ever scored. And if this KPI drives any individual or team incentive, expect effort to drift toward documents that were already likely to pass, since that lifts the ratio without touching the riskiest content in the pipeline. Watching where QC time is actually spent, not just the resulting rate, is the only reliable way to catch that drift early.

Common Pitfalls

Many organizations overlook the importance of regular audits, which can lead to unnoticed inaccuracies in regulatory documents.

  • Failing to implement a centralized document management system can cause inconsistencies. Disparate systems often lead to version control issues and miscommunication among teams, increasing the risk of errors.
  • Neglecting staff training on compliance requirements results in a lack of understanding. Employees may not be aware of the latest regulations, leading to unintentional inaccuracies in documentation.
  • Relying solely on manual processes increases the likelihood of human error. Automation tools can significantly reduce mistakes, yet many organizations resist adopting new technologies.
  • Ignoring feedback from compliance audits can perpetuate existing problems. Without addressing identified issues, organizations risk repeated inaccuracies and potential penalties.

Improvement Levers

Enhancing regulatory document accuracy requires a multifaceted approach focused on process optimization and employee engagement.

  • Implement a robust document management system to streamline workflows. Centralized access ensures all team members work from the most current versions, reducing errors.
  • Conduct regular training sessions on compliance standards and best practices. Continuous education keeps staff informed and engaged, fostering a culture of accuracy.
  • Utilize automated tools for data entry and validation to minimize human error. Automation can significantly enhance operational efficiency and accuracy rates.
  • Establish a feedback loop from compliance audits to identify and rectify weaknesses. Regularly reviewing audit findings helps organizations stay proactive in addressing potential inaccuracies.

KPI Depot is trusted by consulting, strategy, finance, and analytics teams at leading organizations worldwide, including those listed below.

AAMC Accenture AXA Bristol Myers Squibb Capgemini DBS Bank Dell Delta Emirates Global Aluminum EY GSK GlaskoSmithKline Honeywell IBM Mitre Northrup Grumman Novo Nordisk NTT Data PepsiCo Samsung Suntory TCS Tata Consultancy Services Vodafone

Regulatory Document Accuracy Benchmarks

We have 12 relevant benchmarks in our benchmarks database.

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent average rejection rate Aug. 15, 2021 to Apr. 15, 2022. CDER submissions with study data subject to TRC validations. pharmaceutical regulatory submissions. United States.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent average Prior years average and Calendar Year 2018. All CDER submissions with study data. pharmaceutical regulatory submissions. United States.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent failure rate Calendar Year 2018. All CDER submissions with study data (NDA, ANDA, BLA, commer pharmaceutical regulatory submissions. United States. 2,895 submissions with study data.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent failure rate Calendar Year 2018. Commercial IND submissions with study data to CDER. pharmaceutical regulatory submissions. United States. 649 submissions with study data.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent failure rate Calendar Year 2018. BLA submissions with study data to CDER. pharmaceutical regulatory submissions. United States. 291 submissions with study data.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent failure rate Calendar Year 2018. ANDA submissions with study data to CDER. pharmaceutical regulatory submissions. United States. 1,078 submissions with study data.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent failure rate Calendar Year 2018. NDA submissions with study data to CDER. pharmaceutical regulatory submissions. United States. 877 submissions with study data.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent failure rate 12/18/2016 to 3/31/2018 and 12/18/2017 to 3/31/2018 analysis All CDER submissions with study data (NDA, ANDA, BLA, commer pharmaceutical regulatory submissions. United States. 3,221 submissions with study data.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent failure rate 12/18/2017 to 3/31/2018 analysis window. Commercial IND submissions with study data to CDER. pharmaceutical regulatory submissions. United States. 176 submissions with study data.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent failure rate 12/18/2016 to 3/31/2018 analysis window. BLA submissions with study data to CDER. pharmaceutical regulatory submissions. United States. 473 submissions with study data.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent failure rate 12/18/2016 to 3/31/2018 analysis window. ANDA submissions with study data to CDER. pharmaceutical regulatory submissions. United States. 1,446 submissions with study data.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Source: Subscribers only

Source Excerpt: Subscribers only
Formula: Subscribers only

Additional Comments: Subscribers only

Value Unit Type Company Size Time Period Population Industry Geography Sample Size
Subscribers only percent failure rate 12/18/2016 to 3/31/2018 analysis window. NDA submissions with study data to CDER. pharmaceutical regulatory submissions. United States. 1,126 submissions with study data.

Unlock this benchmark, plus all 38,461 source-attributed benchmarks with full values, formulas, and citations.

Compare KPI Depot Plans Login

Browse the Top Benchmarked KPIs in Regulatory Affairs

Reading the Benchmarks for Regulatory Document Accuracy

All twelve tracked sources for this KPI come back to the same regulator, the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, so the spread here is not a story of twelve organizations disagreeing. It is a story of how much one agency's own numbers move once you slice by submission type, time window, and which stage of its review pipeline is doing the counting. That is arguably a harder problem for a reader than cross company disagreement, because a single named regulator looks authoritative no matter which slice is quoted.

The twelve rows split across two separate FDA reports, and the two use different metric types for a reason. The earlier report measures a failure rate against specific technical validation checks in the electronic submission pipeline, checks that at the time were diagnostic rather than a hard gate. The later report measures a rejection rate tied to the FDA's Technical Rejection Criteria for study data, an automated gate that only began actually rejecting noncompliant submissions outright once it took effect. Failure and rejection describe different consequences for the same underlying kind of defect. A submission that failed a check under the earlier regime could still proceed with a deficiency noted; the same defect caught under the later regime can stop the submission before review even starts. Treating a failure rate and a rejection rate as points on one continuous trend compares two different penalties, not two snapshots of the same thing.

Within the earlier report itself, the failure rate is further split by submission type: original new drug applications, generic applications, biologics license applications, and commercial investigational filings, each measured across more than one time window, including overlapping multi year windows that share most of the same underlying period. Original and generic applications are prepared by different kinds of sponsors with different levels of submission maturity, so pooling them erases a real structural difference rather than averaging out noise. Because the multi year windows overlap so heavily, figures that look like independent confirmations of a trend are mostly the same underlying set of submissions counted with slightly different boundaries, not independent readings.

Sample size is the other variable worth checking before trusting any cited figure. The tracked reports range from small populations in the smallest filing category to much larger populations in the largest, and a rate built on a small population moves a great deal on a handful of submissions in either direction. The later rejection rate, on top of that, covers a window in the months right after the rejection gate took effect, an early period when submitters were still adjusting their processes to a new requirement, which is not necessarily where that rate settles once the gate becomes a routine part of filing.

Finally, every one of these twelve sources sits inside pharmaceutical regulatory submissions to one U.S. agency, even though Regulatory Document Accuracy as a concept applies to any document a business files with any regulator. A customer measuring this KPI for environmental permitting, trade compliance, or financial regulatory filings should not import any pattern from this source set at all. Other regulators score document accuracy on entirely different mechanics, whether that is content review after acceptance, sampling based audits, or their own version of an intake gate, and none of that is visible in a dataset built entirely from one agency's drug review pipeline. That is exactly the kind of context a customer only gets from a curated, source attributed benchmark set, not from a single number lifted out of context.

OKRs That Use Regulatory Document Accuracy

Regulatory Affairs' OKR material does not name Regulatory Document Accuracy directly in its worked examples, but two of the group's real objectives depend on it structurally. The first objective, ensuring unwavering adherence to core compliance standards across all operations, is built from key results on Regulatory Compliance Rate, Safety Incident Reporting Compliance, Environmental Compliance Rate, and Pharmacovigilance Compliance Rate. Inaccurate documents are a common root cause behind misses on exactly those rates: a compliance gap often starts as a mistake or omission in the paperwork long before it shows up as a missed compliance figure. A team pursuing that objective could reasonably add a key result under this KPI, framed as a goal to meaningfully cut the share of regulatory documents that need rework before they are considered final, as a leading input to the compliance rates the objective already tracks.

The second objective, accelerating response and resolution of regulatory issues to minimize operational impact, leans on Regulatory Audit Pass Rate and Regulatory Issue Resolution Time as key results, both outcomes downstream of document quality. Fewer inaccurate documents in the pipeline means fewer defects available to surface as audit findings or open issues in the first place. A team working this objective could set itself the goal of steadily reducing the volume of documents flagged for correction after submission, framed as a supporting key result that feeds a faster audit pass rate and a shorter resolution cycle rather than replacing either one.

See OKR Examples for Regulatory Affairs


What is the standard formula?
(Number of Error-Free Documents / Total Number of Regulatory Documents) * 100


Unlock all 38,461 source-attributed benchmarks.
Comparable benchmark data services start at $2,400 per year.
See all 12 benchmarks for Regulatory Document Accuracy
Access to 38,461 benchmarks
Access to 24,181 KPIs
Interactive Strategy Maps on every plan
13 attributes per KPI (view)

Compare Plans

Definitive Guide to Regulatory Affairs KPIs cover
Free Whitepaper
Want to achieve performance excellence in Regulatory Affairs? Download our in-depth whitepaper: Definitive Guide to Regulatory Affairs KPIs.
Download the Free Guide

KPI Categories

This KPI is associated with the following categories and industries in our KPI database:



KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.

The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.

When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.

Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.

Got a question? Email us at [email protected].

FAQs about Regulatory Document Accuracy

What is the ideal accuracy rate for regulatory documents?

An ideal accuracy rate typically hovers around 98% or higher. This threshold ensures compliance and minimizes the risk of penalties.

How often should regulatory documents be audited?

Regular audits should occur at least quarterly. Frequent reviews help identify inaccuracies and maintain compliance with evolving regulations.

What role does employee training play in document accuracy?

Employee training is critical for ensuring understanding of compliance standards. Well-informed staff are less likely to make errors in documentation.

Can automation improve document accuracy?

Yes, automation significantly reduces human error in data entry and validation. Implementing automated tools enhances operational efficiency and accuracy rates.

What are the consequences of low document accuracy?

Low accuracy can lead to costly penalties and damage to reputation. It may also result in operational inefficiencies and resource misallocation.

How can feedback from audits be utilized?

Feedback from audits should inform process improvements and training needs. Addressing identified weaknesses proactively enhances overall accuracy.



Each KPI in our knowledge base includes 13 attributes.

KPI Definition

A clear explanation of what the KPI measures

Potential Business Insights

The typical business insights we expect to gain through the tracking of this KPI

Measurement Approach

An outline of the approach or process followed to measure this KPI

Standard Formula

The standard formula organizations use to calculate this KPI

Trend Analysis

Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts

Diagnostic Questions

Questions to ask to better understand your current position is for the KPI and how it can improve

Actionable Tips

Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions

Visualization Suggestions

Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making

Risk Warnings

Potential risks or warnings signs that could indicate underlying issues that require immediate attention

Tools & Technologies

Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively

Integration Points

How the KPI can be integrated with other business systems and processes for holistic strategic performance management

Change Impact

Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected

BSC Perspective

NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)


Compare Our Plans


Explore KPI Depot by Function & Industry



Connect our complete KPI and benchmark database to your AI